Literature DB >> 6798861

Feline mucopolysaccharidosis VI: purification and characterization of the resident arylsulfatase B activity.

D T Vine, M M McGovern, M E Haskins, R J Desnick.   

Abstract

Hepatic arylsulfatase B (ASB) from normal and mucopolysaccharidosis VI (MPS VI) cats was purified over 2,800- and 1,800-fold, respectively, and their physical and kinetic properties were characterized. In contrast to the normal feline enzyme, the partially purified MPS VI residual activity had a 100-fold greater Km value and was markedly less stable to thermal, cryo-, and pH-inactivation. In addition, the MPS VI enzyme had a more negative charge as determined by its migration on polyacrylamide gel electrophoresis and its elution profile on cation exchange chromatography. Finally, the MPS VI activity had approximately half the apparent molecular weight of the normal feline enzyme, which was a homodimer, suggesting that the genetic mutation in feline MPS VI altered the subunit association as well as the kinetic and stability properties of the mutant protein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798861      PMCID: PMC1685156     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

2.  Studies of human sulfatase "B." I. Purification and properties from liver.

Authors:  K Okada; J Collins; W S Worth; J H Austin
Journal:  Biochem Med       Date:  1975-03

3.  Studies on human erythrocyte inorganic pyrophosphatase.

Authors:  R A Fisher; B M Turner; H L Dorkin; H Harris
Journal:  Ann Hum Genet       Date:  1974-01       Impact factor: 1.670

4.  Some properties of the sulphatase B of ox brain.

Authors:  W S Bleszynski; A B Roy
Journal:  Biochim Biophys Acta       Date:  1973-07-12

5.  Electrophoresis of arylsulfatase from normal individuals and patients with metachromatic leukodystrophy.

Authors:  M C Rattazzi; J S Marks; R G Davidson
Journal:  Am J Hum Genet       Date:  1973-05       Impact factor: 11.025

6.  Reduced arylsulfatase B activity of the mutant enzyme protein in Maroteaux-Lamy syndrome.

Authors:  E Shapira; R R DeGregorio; R Matalon; H L Nadler
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

7.  Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: Cellular studies and carrier identification.

Authors:  N G Beratis; B M Turner; R Weiss; K Hirschhorn
Journal:  Pediatr Res       Date:  1975-05       Impact factor: 3.756

8.  Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). I. Sulfatase B deficiency in tissues.

Authors:  D A Stumpf; J H Austin; A C Crocker; M LaFrance
Journal:  Am J Dis Child       Date:  1973-12

9.  Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts.

Authors:  A L Fluharty; R L Stevens; D L Sanders; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  4 in total

1.  Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.

Authors:  D T Vine; M M McGovern; E H Schuchman; M E Haskins; R J Desnick
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

Review 2.  Ocular manifestations of systemic disease in cats.

Authors:  Noelle C La Croix
Journal:  Clin Tech Small Anim Pract       Date:  2005-05

3.  Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.

Authors:  Leslie A Lyons; Robert A Grahn; Francesca Genova; Michela Beccaglia; John J Hopwood; Maria Longeri
Journal:  BMC Vet Res       Date:  2016-07-02       Impact factor: 2.741

Review 4.  Mucopolysaccharidosis Type VI, an Updated Overview of the Disease.

Authors:  Francesca D'Avanzo; Alessandra Zanetti; Concetta De Filippis; Rosella Tomanin
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.